A guide for US healthcare professionals responsible for population-based decision making Help clinicians identify the subset of patients with clinical characteristics of advanced polycythemia vera (PV) Format: PDF Presented by Incyte Posted...
A Practice Manager’s Perspective on Quality Initiatives for Patients With Myeloproliferative Neoplasms (MPNs) Kellie J. Mozingo, Executive Director, Vita Medical Associates, P.C. in Bethlehem, PA Format: PDF Presented by Incyte Posted...
A Physician’s Perspective on Quality Initiatives for Patients With Myeloproliferative Neoplasms (MPNs) splenomegaly and symptoms may affect them, so they can take an active role in their care. John Paul Winters III, MD Staff Physician, Hematology/Oncology Maine Center...
A patient counseling resource to support: Proactive identification of splenomegaly and symptoms associated with myelofibrosis Myelofibrosis (MF) is a serious hematologic malignancy characterized by splenomegaly and a substantial symptom burden that can have a profound...
Patient Care in Polycythemia Vera: An Advanced Practice Provider’s Perspective Amber N. Essenmacher, PA-C, MMS Medical Science Liaison at Incyte Corporation To gain additional insight into the management of polycythemia vera (PV) by advanced practice providers(APPs),...
